|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-4.49% | -0.54% |
| 22-03-28 | Novelion Therapeutics Inc. Announces Final Cash Distribution, Payable on or About March 31, 2022 | CI |
| 20-01-16 | Novelion Therapeutics Inc. Announces Management Changes | CI |
| Market Cap | 13.85M 12.06M 11.41M 10.37M 19.37M 1.33B 19.47M 136M 52.57M 674M 52.02M 50.86M 2.16B | P/E 2017 |
-0.46x | P/E 2018 | -0.15x |
|---|---|---|---|---|---|
| Enterprise Value | 317M 276M 261M 238M 444M 30.38B 446M 3.11B 1.2B 15.44B 1.19B 1.17B 49.42B | EV / Sales 2017 |
1,887,512x | EV / Sales 2018 | 2,447,567x |
| Free-Float |
-
| Yield 2017 * |
-
| Yield 2018 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/9/20 | Edgepoint Investment Group, Inc.
| Buy | Company | 1,317 | 0.0067% | |
| 4/9/20 | Edgepoint Investment Group, Inc.
| Other | Company | 0 | 0% | - |
| 4/9/20 | Edgepoint Investment Group, Inc.
| Sell | Company | 750,000 | 3.8228% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 138.44 120.58 114.12 103.69 193.7 13.26K 194.66 1.36K 525.59 6.74K 520.06 508.48 21.57K | 130.43 113.61 107.52 97.69 182.5 12.49K 183.4 1.28K 495.2 6.35K 489.98 479.08 20.32K |
| Net income | -127M -110M -104M -94.9M -177M -12.14B -178M -1.24B -481M -6.17B -476M -465M -19.74B | -108M -94.35M -89.3M -81.13M -152M -10.37B -152M -1.06B -411M -5.27B -407M -398M -16.88B |
| Net Debt | 203M 177M 167M 152M 284M 19.45B 286M 1.99B 771M 9.89B 763M 746M 31.65B | 303M 264M 250M 227M 424M 29.05B 427M 2.98B 1.15B 14.76B 1.14B 1.11B 47.26B |
Employees
-
Sector
-
- Stock Market
- Stocks
- NVLNF Stock
Select your edition
All financial news and data tailored to specific country editions
